Events Partner Content Applied Biocatalysis Summit 2020 Advancing Sustainable, Streamlined API and Chemical Production using Enzyme Engineering & Scalable Biocata
News FDA clears Nuvation's first product Ibtrozi, for lung cancer Nuvation is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment for ROS1-positive lung cancer.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
